BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 15486744)

  • 1. Anorectal pathology in HIV/AIDS-infected patients has not been impacted by highly active antiretroviral therapy.
    Gonzalez-Ruiz C; Heartfield W; Briggs B; Vukasin P; Beart RW
    Dis Colon Rectum; 2004 Sep; 47(9):1483-6. PubMed ID: 15486744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of perianal diseases in HIV-positive patients during periods before and after protease inhibitors use: what changed in the 21st century.
    Nadal SR; Manzione CR; Horta SH
    Dis Colon Rectum; 2008 Oct; 51(10):1491-4. PubMed ID: 18670819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation and description of anal pathology in HIV-infected patients during the HAART era.
    Abramowitz L; Benabderrahmane D; Baron G; Walker F; Yeni P; Duval X
    Dis Colon Rectum; 2009 Jun; 52(6):1130-6. PubMed ID: 19581857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anorectal diseases in HIV-positive patients. A prospective study].
    Sánchez Valdez G; Vieyra Antero FJ; Peña Ruiz Esparza JP; Villanueva Sáenz E
    Rev Gastroenterol Mex; 1998; 63(2):89-92. PubMed ID: 10068734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anorectal surgery in patients infected with human immunodeficiency virus].
    Geminiano-Martínez EE; Ruíz-Esparza JP; Villanueva-Sáenz E; Alvarez-Tostado Fernández JF; Parrado-Montaño J
    Rev Gastroenterol Mex; 2000; 65(4):152-8. PubMed ID: 11464608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevalence of ano-rectal pathology in HIV/AIDS patients].
    Muñoz C C; Mansilla E JA; Heider C C; Leal W MJ; Chain A C
    Rev Chilena Infectol; 2012 Feb; 29(1):95-8. PubMed ID: 22552518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy.
    Antinori A; Larussa D; Cingolani A; Lorenzini P; Bossolasco S; Finazzi MG; Bongiovanni M; Guaraldi G; Grisetti S; Vigo B; Gigli B; Mariano A; Dalle Nogare ER; De Marco M; Moretti F; Corsi P; Abrescia N; Rellecati P; Castagna A; Mussini C; Ammassari A; Cinque P; d'Arminio Monforte A;
    Clin Infect Dis; 2004 Dec; 39(11):1681-91. PubMed ID: 15578371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence.
    Gaitan Cepeda LA; Ceballos Salobreña A; López Ortega K; Arzate Mora N; Jiménez Soriano Y
    Med Oral Patol Oral Cir Bucal; 2008 Feb; 13(2):E85-93. PubMed ID: 18223535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy.
    Wexler A; Berson AM; Goldstone SE; Waltzman R; Penzer J; Maisonet OG; McDermott B; Rescigno J
    Dis Colon Rectum; 2008 Jan; 51(1):73-81. PubMed ID: 18066626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of GB virus C viremia on patients with HIV type 1 infection in the era of highly active antiretroviral therapy.
    Sheng WH; Hung CC; Wu RJ; Wang JT; Chen PJ; Chang SC; Kao JH
    Clin Infect Dis; 2007 Feb; 44(4):584-90. PubMed ID: 17243064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adipokines and highly active antiretroviral therapy related lipodystrophy: clinical study of 52 cases].
    Tao MM; Zhang L; Qiu ZF; Xie J; Han Y; Yu W; Li M; Li TS
    Zhonghua Yi Xue Za Zhi; 2009 Apr; 89(13):867-71. PubMed ID: 19671283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment of anorectal disorders in 32 HIV-seropositive patients].
    Sars PR; Slors JF; Taat CW
    Ned Tijdschr Geneeskd; 1994 Jun; 138(24):1227-30. PubMed ID: 8015620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
    Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
    Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorectal pathology in AIDS.
    Brar HS; Gottesman L; Surawicz C
    Gastrointest Endosc Clin N Am; 1998 Oct; 8(4):913-31. PubMed ID: 9730939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anorectal disorders requiring surgical treatment in the University of Port Harcourt Teaching Hospital, Port Harcourt.
    Adotey JM; Jebbin NJ
    Niger J Med; 2004; 13(4):350-4. PubMed ID: 15523860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival of HIV-infected patients treated with highly active antiretroviral therapy in Serbia and Montenegro.
    Jevtović DO; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2007 Mar; 8(2):75-9. PubMed ID: 17352762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.